Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
195K
-
Shares change
-
-26.6K
-
Total reported value, excl. options
-
$1.6M
-
Value change
-
-$122K
-
Number of sells
-
-2
-
Price
-
$8.36
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2023
3 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q4 2023.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 195K shares
of 334M outstanding shares and own 0.06% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (22.8M shares), MHR FUND MANAGEMENT LLC (20M shares), BlackRock Inc. (19.1M shares), STATE STREET CORP (16.4M shares), PERCEPTIVE ADVISORS LLC (12M shares), Avoro Capital Advisors LLC (6.7M shares), Pictet Asset Management Holding SA (5.26M shares), GEODE CAPITAL MANAGEMENT, LLC (5.04M shares), Artisan Partners Limited Partnership (4.83M shares), and ORBIMED ADVISORS LLC (4.71M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.